RESEARCH-USE BIOSIMILAR ANTIBODY
Vatelizumab
Monoclonal antibody · IgG4
Vatelizumab (GBR500) is a monoclonal antibody that targets the α2 subunit (CD49b) of very late antigen 2 (VLA-2). Vatelizumab can be used for research on multiple sclerosis.
TARGETIGTA2
YMonoclonal antibody
CATALOGSC-BS-054
CATALOG NUMBERSC-BS-054
MOLECULAR WEIGHTApprox. 144.28 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Vatelizumab (GBR500) is a monoclonal antibody that targets the α2 subunit (CD49b) of very late antigen 2 (VLA-2). Vatelizumab can be used for research on multiple sclerosis.
Vatelizumab is a recombinant research-use antibody directed against IGTA2.